Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
KSQ Therapeutics
Biotech
Roche inks KSQ deal to expand stable of synthetic lethal assets
The Swiss drug developer has secured an exclusive global license to KSQ Therapeutics’ early-phase USP1 inhibitor.
Nick Paul Taylor
Jul 13, 2023 9:20am
Takeda puts $510M on the line to expand KSQ cancer collaboration
May 17, 2023 9:35am
Japan's Ono signs up for KSQ's preclinical cancer programs
Jan 25, 2023 9:55am
PARP combo shows promise in ovarian and breast cancer models
Oct 24, 2020 4:00am